BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1831385)

  • 1. In-vitro DNA synthesis of keratinocytes in normal human skin, psoriasis, seborrhoeic keratosis, Bowen's disease and basal cell carcinoma.
    Morimoto Y; Saga K; Bando M; Takahashi M
    Br J Dermatol; 1991 Jul; 125(1):9-13. PubMed ID: 1831385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin expression in hyperproliferative skin diseases.
    Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie EJ
    Br J Dermatol; 1991 Jan; 124(1):13-20. PubMed ID: 1704250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular metabolism in hyperplastic epidermal disease--a radio-autographic study.
    Arndt KA; Freedberg IM
    Br J Dermatol; 1974 Nov; 91(5):541-8. PubMed ID: 4279689
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 immunoreactivity in malignant tumours of the skin.
    Bornscheuer E; Schröder JM; Christophers E; Sticherling M
    Acta Derm Venereol; 1996 May; 76(3):210-3. PubMed ID: 8800301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas.
    Rahkola D; Laitala J; Siiskonen H; Pelkonen J; Harvima IT
    Cancer Invest; 2019; 37(2):73-84. PubMed ID: 30689427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of endothelins and their receptors in nonmelanoma skin cancers.
    Zhang Y; Tang L; Su M; Eisen D; Zloty D; Warshawski L; Zhou Y
    J Cutan Med Surg; 2006; 10(6):269-76. PubMed ID: 17241596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nuclear DNA analysis of benign skin tumor and carcinoma in site developed from keratinocyte].
    Toyoshima H; Hori M; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):527-31. PubMed ID: 1890748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
    Jang TJ
    Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
    J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease.
    Amagai M; Ozawa S; Ueda M; Nishikawa T; Abe O; Shimizu N
    Br J Dermatol; 1988 Nov; 119(5):661-8. PubMed ID: 3207620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichilemmal tumor arising in a seborrheic keratosis: analysis of cell kinetics by BrdU staining.
    Kitagawa K; Amagai M; Miyakawa S; Hayakawa K; Ueda M; Shimizu N
    J Dermatol; 1991 Jun; 18(6):334-9. PubMed ID: 1719052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
    Takeda A; Nonaka M; Ishikawa A; Higuchi D
    Arch Dermatol Res; 1999 Apr; 291(4):238-40. PubMed ID: 10335922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.